Results 231 to 240 of about 87,642 (357)

Associations between clinical signs, endoscopic and cytological findings in equine bronchoalveolar lavage samples

open access: yesEquine Veterinary Education, EarlyView.
Summary Background Endoscopy, including tracheal mucus score (TMS) and bronchoalveolar lavage (BAL) fluid cytology, is commonly employed in the diagnosis of equine asthma (EA). Large‐scale studies comparing clinical signs, TMS and BAL cytology are warranted.
M. Larsen   +5 more
wiley   +1 more source

Differences in pulmonary function measured by oscillometry between horses with mild–moderate equine asthma and healthy controls

open access: yesEquine Veterinary Journal, Volume 57, Issue 3, Page 619-628, May 2025.
Abstract Background The diagnosis of mild–moderate equine asthma (MEA) can be confirmed by airway endoscopy, bronchoalveolar lavage fluid (BALf) cytology, and lung function evaluation by indirect pleural pressure measurement. Oscillometry is a promising pulmonary function test method, but its ability to detect subclinical airway obstruction has been ...
Chiara Maria Lo Feudo   +5 more
wiley   +1 more source

In Asthmatic Patients, Sexual Dimorphism correlates With Androgen Receptor Expression in ILC2s at Single Cell‐Resolution

open access: yes
Clinical &Experimental Allergy, EarlyView.
Nina Anesi   +8 more
wiley   +1 more source

Should We Advance Our Understanding of Immunoglobulin E in Viral Immunity?

open access: yesImmunology, EarlyView.
Immunoglobulin E has been extensively studied in allergies and parasitic diseases. Antigen‐specific IgE has been identified as part of the humoral response to viruses. This revision speculates on possible functionalities for IgE, such as neutralisation, cytotoxicity and immunopathology of viral diseases, and provide insights about gaps to fill in ...
Amanda Izeli Portilho   +3 more
wiley   +1 more source

European Guideline (EuroGuiDerm) on atopic eczema: Living update

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
The updated guideline includes a new evidence‐based recommendation for the IL‐13 inhibitor lebrikizumab. In addition, the Janus kinase inhibitors baricitinib and abrocitinib, which were initially only approved for adult patients, are now also recommended for children from the age of 2 and adolescents from the age of 12, respectively.
A. Wollenberg   +31 more
wiley   +1 more source

Clinical Predictors of Longitudinal Respiratory Exacerbation Outcomes in Young Hospitalised Children

open access: yes
Clinical &Experimental Allergy, EarlyView.
Laura A. Coleman   +8 more
wiley   +1 more source

Dupilumab shows no elevated risk for maternal adverse pregnancy outcomes: A propensity‐matched cohort study

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This large‐scale, propensity‐matched retrospective cohort study provides evidence that dupilumab treatment during pregnancy is not associated with an elevated risk of maternal adverse pregnancy outcomes (APOs). By utilizing real‐world data, it contributes critical insights into dupilumab's safety profile in pregnant women, addressing a crucial gap in ...
Sophie L. Preuß   +9 more
wiley   +1 more source

Efficacy and Safety of Mepolizumab in the Management of Severe Eosinophilic Asthma: A Systematic Review. [PDF]

open access: yesCureus, 2023
Dighriri IM   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy